Last Posted: Feb 11, 2020
- BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients.
Dika Emi, et al. American journal of clinical pathology 2020 2
- Low BRAF V600 mutation prevalence in primary skin nodular melanoma in Indonesia: a real-time PCR detection among Javanese patients.
Rinonce Hanggoro Tri, et al. BMC proceedings 2019 0 (Suppl 11) 15
- Frequency of BRAF V600E Mutation in the Mexican Population of Patients With Metastatic Melanoma.
Ruiz-Garcia Erika, et al. Journal of global oncology 2018 9 (4) 1-5
- Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.
Lattanzi Michael et al. Journal of the National Cancer Institute 2018 Jun
- Genotyping and differential expression analysis of inflammasome genes in sporadic malignant melanoma reveal novel contribution of CARD8, IL1B and IL18 in melanoma susceptibility and progression.
da Silva Wanessa Cardoso, et al. Cancer genetics 2016 10 (10) 474-480
- Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma.
Yaman Banu, et al. The American Journal of dermatopathology 2015 5 (5) 389-97
- Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients.
Baiter Mirjam, et al. Dermatology (Basel, Switzerland) 2015 0 (2) 127-33
- Melanoma risk is associated with vitamin D receptor gene polymorphisms.
Zeljic Katarina, et al. Melanoma research 2014 6 (3) 273-9
- Amelanotic acral melanomas: clinicopathological, BRAF mutation, and KIT aberration analyses.
Choi Yoo Duk, et al. Journal of the American Academy of Dermatology 2013 11 (5) 700-7
- KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.
Campillo JA, et al. Immunogenetics 2013 1
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.